SWTX - SpringWorks Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
Total Revenue
0
0
Cost of Revenue
-
-
Gross Profit
-
-
Operating Expenses
Research Development
26,740
9,898
Selling General and Administrative
11,476
8,593
Total Operating Expenses
38,216
18,491
Operating Income or Loss
-38,216
-18,491
Interest Expense
-
-
Total Other Income/Expenses Net
-
-
Income Before Tax
-36,479
-17,813
Income Tax Expense
-
-
Income from Continuing Operations
-36,479
-17,813
Net Income
-36,479
-17,813
Net Income available to common shareholders
-28,750
-17,813
Reported EPS
Basic
-
-2.00
Diluted
-
-2.00
Weighted average shares outstanding
Basic
-
8,927
Diluted
-
8,927
EBITDA
-
-18,474